Patricia Melnyk

This inventor holds 10 USPTO granted patents and 4 published patent applications, plus 3 CIPO patents and 5 EPO patents. Top assignees: National Institute of Health and Medical Research, Université De Lille 2 Droit Et Santé, Alzprotect. Active years: 2014-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Patricia Melnyk. Retrieved from https://idiyas.com/inventor/patricia-melnyk

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10 (Patent Applications = 4)

% Patents Active = 80.0

CIPO Patents = 3

EPO Patents = 5 (Patent Applications = 8)

Average Co-Inventor Count = 5.5

ph-index = 1

Forward Citations = 3(Granted Patents)

Location History:

Lille Cedex, FR (2014)
Annouellin, FR (2017)
Annoeullin, FR (2015 - 2020)
Lille, FR (2018 - 2020)
Annoellin, FR (2020)

Company Filing History:

7 out of 1,853

National Institute of Health and Medical Research

patents

6 out of 13

Université De Lille 2 Droit Et Santé

Centre Hospitalier Regional Et Universitaire De Lille (Chru)

patents

5. 1 out of 5,383

Centre National De La Recherche Scientifique

patents

6. 1 out of 1

Universite De Lille 2 Droit Et Saute

patent

7. 1 out of 1

Universite Du Droit Et De La Santa-Lille Ii

patent

8. 1 out of 9

Université Lille 1 - Sciences Et Technologies

patents

9. 1 out of 6

Université Lille 2 - Droit Et Santé

patents

where one patent can have more than one assignee

Years Active: 2014-2020

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10844008 - Compounds, pharmaceutical composition and their use in treating neurodegenerative diseases (2020-11-24),

2. 10807958 - 1,4-bis(3-aminopropyl)piperazine derivative and its use (2020-10-20),

3. 10772884 - Sulphate salts of N-(3-(4-(3-(diisobutylamino)propyl)piperazin-1-yl)propyl)-1H-benzo[d]imidazol-2-amine, preparation thereof and use of the same (2020-09-15),

4. 10537569 - Sulphate salts of N-(3-(4-(3-(diisobutylamino)propyl)piperazin-1-yl)propyl)-1H-benzo[d]imidazol-2-amine, preparation thereof and use of the same (2020-01-21),

5. 10179761 - Compounds, pharmaceutical composition and their use in treating neurodegenerative diseases (2019-01-15),

6. 10017476 - 1,4-bis(3-aminopropyl)piperazine derivative and its use (2018-07-10),

7. 9714245 - Carboline compounds usable in the treatment of neurodegenerative diseases (2017-07-25),

8. 9562018 - Sulphate salts of N-(3-(4-(3-(diisobutylamino)propyl)piperazin-1-yl)propyl)-1H-benzo[d]imidazol-2-amine, preparation thereof and use of the same (2017-02-07),

9. 9044478 - Use of 1,4-bis (3-aminoalkyl) piperazine derivatives in the treatment of neurodegenerative diseases (2015-06-02),

10. 8680095 - Heterocycle compounds and uses thereof for the prevention or treatment of diseases involving formation of amyloid plaques and/or where a dysfunction of the APP metabolism occurs (2014-03-25),

Title: Patricia Melnyk: Innovator in Neurodegenerative Disease Treatment

Introduction

Patricia Melnyk is a prominent inventor based in Annoeullin, France. She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of neurodegenerative diseases. With a total of 10 patents to her name, her work has the potential to impact many lives.

Latest Patents

Among her latest patents, one notable invention is directed to novel compounds of Formula (I), pharmaceutically acceptable salts or solvates thereof, and their use in treating neurodegenerative diseases. Another significant patent involves a 1,4-bis(3-aminopropyl)piperazine derivative and its use in treating and/or preventing a Tauopathy. These innovations highlight her commitment to advancing medical science.

Career Highlights

Throughout her career, Patricia has worked with esteemed institutions such as the Institut National de la Santé et de la Recherche Médicale and the Université de Lille 2 Droit et Santé. Her work in these organizations has allowed her to collaborate with leading experts in the field, further enhancing her research and development efforts.

Collaborations

Patricia has collaborated with notable colleagues, including Nicolas Sergeant and Luc Buee. These partnerships have contributed to her success and the advancement of her research.

Conclusion

Patricia Melnyk's innovative work in the pharmaceutical field, particularly in neurodegenerative disease treatment, showcases her dedication to improving healthcare. Her numerous patents and collaborations reflect her significant impact on medical research and development.

Profile summary based on public USPTO records.